title: Editorial Commentary: Pseudomonas aeruginosa Eradication: How Do We Measure Success?
authors.affiliation: Department of Pediatrics, University of Colorado School of Medicine, Aurora.
authors.forename: Edith T
authors.initials: ET
authors.lastname: Zemanick
authors.affiliation: Department of Pediatrics, University of Minnesota School of Medicine, Minneapolis.
authors.forename: Theresa A
authors.initials: TA
authors.lastname: Laguna
mesh_terms: D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D003550:Cystic Fibrosis / Q000453:epidemiology* / Q000382:microbiology*; D005260:Female; D006801:Humans; D008297:Male; D011552:Pseudomonas Infections / Q000188:drug therapy* / Q000453:epidemiology*; D011550:Pseudomonas aeruginosa
chemical_list: D000900:Anti-Bacterial Agents
keywords: Pseudomonas; airway infection; cystic fibrosis; eradication; outcomes